102 related articles for article (PubMed ID: 26725028)
1. Benzylamide antagonists of protease activated receptor 2 with anti-inflammatory activity.
Yau MK; Liu L; Lim J; Lohman RJ; Cotterell AJ; Suen JY; Vesey DA; Reid RC; Fairlie DP
Bioorg Med Chem Lett; 2016 Feb; 26(3):986-991. PubMed ID: 26725028
[TBL] [Abstract][Full Text] [Related]
2. Modulating human proteinase activated receptor 2 with a novel antagonist (GB88) and agonist (GB110).
Suen JY; Barry GD; Lohman RJ; Halili MA; Cotterell AJ; Le GT; Fairlie DP
Br J Pharmacol; 2012 Mar; 165(5):1413-23. PubMed ID: 21806599
[TBL] [Abstract][Full Text] [Related]
3. Antagonism of protease-activated receptor 2 protects against experimental colitis.
Lohman RJ; Cotterell AJ; Suen J; Liu L; Do AT; Vesey DA; Fairlie DP
J Pharmacol Exp Ther; 2012 Feb; 340(2):256-65. PubMed ID: 22028393
[TBL] [Abstract][Full Text] [Related]
4. Discovery of 2-aryloxy-4-amino-quinazoline derivatives as novel protease-activated receptor 2 (PAR2) antagonists.
Cho NC; Cha JH; Kim H; Kwak J; Kim D; Seo SH; Shin JS; Kim T; Park KD; Lee J; No KT; Kim YK; Lee KT; Pae AN
Bioorg Med Chem; 2015 Dec; 23(24):7717-27. PubMed ID: 26631441
[TBL] [Abstract][Full Text] [Related]
5. PAR2-induced inflammatory responses in human kidney tubular epithelial cells.
Vesey DA; Suen JY; Seow V; Lohman RJ; Liu L; Gobe GC; Johnson DW; Fairlie DP
Am J Physiol Renal Physiol; 2013 Mar; 304(6):F737-50. PubMed ID: 23283995
[TBL] [Abstract][Full Text] [Related]
6. Novel agonists and antagonists for human protease activated receptor 2.
Barry GD; Suen JY; Le GT; Cotterell A; Reid RC; Fairlie DP
J Med Chem; 2010 Oct; 53(20):7428-40. PubMed ID: 20873792
[TBL] [Abstract][Full Text] [Related]
7. Pathway-selective antagonism of proteinase activated receptor 2.
Suen JY; Cotterell A; Lohman RJ; Lim J; Han A; Yau MK; Liu L; Cooper MA; Vesey DA; Fairlie DP
Br J Pharmacol; 2014 Sep; 171(17):4112-24. PubMed ID: 24821440
[TBL] [Abstract][Full Text] [Related]
8. A Potent Antagonist of Protease-Activated Receptor 2 That Inhibits Multiple Signaling Functions in Human Cancer Cells.
Jiang Y; Yau MK; Lim J; Wu KC; Xu W; Suen JY; Fairlie DP
J Pharmacol Exp Ther; 2018 Feb; 364(2):246-257. PubMed ID: 29263243
[TBL] [Abstract][Full Text] [Related]
9. An antagonist of human protease activated receptor-2 attenuates PAR2 signaling, macrophage activation, mast cell degranulation, and collagen-induced arthritis in rats.
Lohman RJ; Cotterell AJ; Barry GD; Liu L; Suen JY; Vesey DA; Fairlie DP
FASEB J; 2012 Jul; 26(7):2877-87. PubMed ID: 22467762
[TBL] [Abstract][Full Text] [Related]
10. Protease-activated receptor 1 and 2 contribute to angiotensin II-induced activation of adventitial fibroblasts from rat aorta.
He RQ; Tang XF; Zhang BL; Li XD; Hong MN; Chen QZ; Han WQ; Gao PJ
Biochem Biophys Res Commun; 2016 Apr; 473(2):517-23. PubMed ID: 27012211
[TBL] [Abstract][Full Text] [Related]
11. Protease-activated receptor-2 ligands reveal orthosteric and allosteric mechanisms of receptor inhibition.
Kennedy AJ; Sundström L; Geschwindner S; Poon EKY; Jiang Y; Chen R; Cooke R; Johnstone S; Madin A; Lim J; Liu Q; Lohman RJ; Nordqvist A; Fridén-Saxin M; Yang W; Brown DG; Fairlie DP; Dekker N
Commun Biol; 2020 Dec; 3(1):782. PubMed ID: 33335291
[TBL] [Abstract][Full Text] [Related]
12. Protease activated receptor 2 (PAR2) modulators: a patent review (2010-2015).
Yau MK; Lim J; Liu L; Fairlie DP
Expert Opin Ther Pat; 2016; 26(4):471-83. PubMed ID: 26936077
[TBL] [Abstract][Full Text] [Related]
13. PAR2 Modulators Derived from GB88.
Yau MK; Liu L; Suen JY; Lim J; Lohman RJ; Jiang Y; Cotterell AJ; Barry GD; Mak JY; Vesey DA; Reid RC; Fairlie DP
ACS Med Chem Lett; 2016 Dec; 7(12):1179-1184. PubMed ID: 27994760
[TBL] [Abstract][Full Text] [Related]
14. Pharmacophore-based virtual screening, biological evaluation and binding mode analysis of a novel protease-activated receptor 2 antagonist.
Cho NC; Seo SH; Kim D; Shin JS; Ju J; Seong J; Seo SH; Lee I; Lee KT; Kim YK; No KT; Pae AN
J Comput Aided Mol Des; 2016 Aug; 30(8):625-37. PubMed ID: 27600555
[TBL] [Abstract][Full Text] [Related]
15. Biased Signaling by Agonists of Protease Activated Receptor 2.
Jiang Y; Yau MK; Kok WM; Lim J; Wu KC; Liu L; Hill TA; Suen JY; Fairlie DP
ACS Chem Biol; 2017 May; 12(5):1217-1226. PubMed ID: 28169521
[TBL] [Abstract][Full Text] [Related]
16. Toward drugs for protease-activated receptor 2 (PAR2).
Yau MK; Liu L; Fairlie DP
J Med Chem; 2013 Oct; 56(19):7477-97. PubMed ID: 23895492
[TBL] [Abstract][Full Text] [Related]
17. The C-terminus of murine S100A9 protein inhibits hyperalgesia induced by the agonist peptide of protease-activated receptor 2 (PAR2).
Dale CS; Cenac N; Britto LR; Juliano MA; Juliano L; Vergnolle N; Giorgi R
Br J Pharmacol; 2006 Oct; 149(4):374-84. PubMed ID: 16967049
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of FSLLRY-NH
Lee YJ; Kim SJ; Kwon KW; Lee WM; Im WJ; Sohn UD
Arch Pharm Res; 2017 Jul; 40(7):854-863. PubMed ID: 28643288
[TBL] [Abstract][Full Text] [Related]
19. Three Homology Models of PAR2 Derived from Different Templates: Application to Antagonist Discovery.
Perry SR; Xu W; Wirija A; Lim J; Yau MK; Stoermer MJ; Lucke AJ; Fairlie DP
J Chem Inf Model; 2015 Jun; 55(6):1181-91. PubMed ID: 26000704
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory effect of Lonicera japonica in proteinase-activated receptor 2-mediated paw edema.
Tae J; Han SW; Yoo JY; Kim JA; Kang OH; Baek OS; Lim JP; Kim DK; Kim YH; Bae KH; Lee YM
Clin Chim Acta; 2003 Apr; 330(1-2):165-71. PubMed ID: 12636936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
